243 related articles for article (PubMed ID: 22864740)
1. Physicochemical characterization and an injection formulation study of water insoluble ZCVI₄-2, a novel NO-donor anticancer compound.
Gao Y; Li L; Zhang J; Su F; Gong Z; Lai Y; Zhang Y
Arch Pharm Res; 2012 Jul; 35(7):1177-86. PubMed ID: 22864740
[TBL] [Abstract][Full Text] [Related]
2. Interaction characteristics with bovine serum albumin and retarded nitric oxide release of ZCVI₄-2, a new nitric oxide-releasing derivative of oleanolic acid.
Zhang J; Gao Y; Su F; Gong Z; Zhang Y
Chem Pharm Bull (Tokyo); 2011; 59(6):734-41. PubMed ID: 21628910
[TBL] [Abstract][Full Text] [Related]
3. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
Fini A; Cavallari C; Ospitali F
Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
[TBL] [Abstract][Full Text] [Related]
4. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
[TBL] [Abstract][Full Text] [Related]
5. In vivo and in vitro evaluation of a solid dispersion system of gliclazide:PEG 6000.
Asyarie S; Rachmawati H
PDA J Pharm Sci Technol; 2007; 61(5):400-10. PubMed ID: 18047178
[TBL] [Abstract][Full Text] [Related]
6. Micelles from PEO-PPO-PEO block copolymers as nanocontainers for solubilization of a poorly water soluble drug hydrochlorothiazide.
Kadam Y; Yerramilli U; Bahadur A; Bahadur P
Colloids Surf B Biointerfaces; 2011 Mar; 83(1):49-57. PubMed ID: 21123038
[TBL] [Abstract][Full Text] [Related]
7. Cocrystallization and amorphization induced by drug-excipient interaction improves the physical properties of acyclovir.
Masuda T; Yoshihashi Y; Yonemochi E; Fujii K; Uekusa H; Terada K
Int J Pharm; 2012 Jan; 422(1-2):160-9. PubMed ID: 22079714
[TBL] [Abstract][Full Text] [Related]
8. Preparation, characterization and in vivo assessment of the bioavailability of glycyrrhizic acid microparticles by supercritical anti-solvent process.
Sui X; Wei W; Yang L; Zu Y; Zhao C; Zhang L; Yang F; Zhang Z
Int J Pharm; 2012 Feb; 423(2):471-9. PubMed ID: 22183131
[TBL] [Abstract][Full Text] [Related]
9. Solid-state characterization of tacrine hydrochloride.
Sorrenti M; Catenacci L; Bruni G; Luppi B; Bigucci F; Bettinetti G
J Pharm Biomed Anal; 2012 Apr; 63():53-61. PubMed ID: 22326286
[TBL] [Abstract][Full Text] [Related]
10. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
[TBL] [Abstract][Full Text] [Related]
11. Preparation and pharmacokinetic evaluation of curcumin solid dispersion using Solutol® HS15 as a carrier.
Seo SW; Han HK; Chun MK; Choi HK
Int J Pharm; 2012 Mar; 424(1-2):18-25. PubMed ID: 22226878
[TBL] [Abstract][Full Text] [Related]
12. Comparison of different methods for preparation of a stable riccardin D formulation via nano-technology.
Liu G; Zhang D; Jiao Y; Zheng D; Liu Y; Duan C; Jia L; Zhang Q; Lou H
Int J Pharm; 2012 Jan; 422(1-2):516-22. PubMed ID: 22119965
[TBL] [Abstract][Full Text] [Related]
13. Improving the solubility of ampelopsin by solid dispersions and inclusion complexes.
Ruan LP; Yu BY; Fu GM; Zhu DN
J Pharm Biomed Anal; 2005 Jul; 38(3):457-64. PubMed ID: 15925247
[TBL] [Abstract][Full Text] [Related]
14. Influence of particle size and preparation methods on the physical and chemical stability of amorphous simvastatin.
Zhang F; Aaltonen J; Tian F; Saville DJ; Rades T
Eur J Pharm Biopharm; 2009 Jan; 71(1):64-70. PubMed ID: 18703139
[TBL] [Abstract][Full Text] [Related]
15. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization.
Liu J; Gong T; Wang C; Zhong Z; Zhang Z
Int J Pharm; 2007 Aug; 340(1-2):153-62. PubMed ID: 17428627
[TBL] [Abstract][Full Text] [Related]
16. Physicochemical and pharmacokinetic characterization of water-soluble Coenzyme Q(10) formulations.
Hatanaka J; Kimura Y; Lai-Fu Z; Onoue S; Yamada S
Int J Pharm; 2008 Nov; 363(1-2):112-7. PubMed ID: 18706989
[TBL] [Abstract][Full Text] [Related]
17. Effect of pharmaceutically acceptable glycols on the stability of the liquid crystalline gels formed by Poloxamer 407 in water.
Ivanova R; Lindman B; Alexandridis P
J Colloid Interface Sci; 2002 Aug; 252(1):226-35. PubMed ID: 16290783
[TBL] [Abstract][Full Text] [Related]
18. Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process.
Kim MS; Jin SJ; Kim JS; Park HJ; Song HS; Neubert RH; Hwang SJ
Eur J Pharm Biopharm; 2008 Jun; 69(2):454-65. PubMed ID: 18359211
[TBL] [Abstract][Full Text] [Related]
19. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
Psathas PA; Kuzmission A; Ikeda K; Yasuo S
Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
[TBL] [Abstract][Full Text] [Related]
20. Solubilization of indomethacin using hydrotropes for aqueous injection.
Jain AK
Eur J Pharm Biopharm; 2008 Mar; 68(3):701-14. PubMed ID: 17716879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
